pubmed tesamorelin ipamorelin 2X Blend & Tesamorelin/Ipamorelin(3mg/0.3mg / 10ml vial) -

Our clients dont just feel better

Always swirl or roll

CJC-1295 Backbone Clinical Data Relevant to the No-DAC Research Profile Two randomised, placebo-controlled, double-blind, ascending-dose clinical trials of CJC-1295 DAC which shares the same tetrasubstituted GHRH backbone as the no-DAC variant produced dose-dependent increases in mean plasma GH concentrations of 2 to 10-fold for 6 days or more, and mean IGF-1 concentrations of 1.5 to 3-fold for 911 days

Schafer, G., Prkachin, K

While theyre increasingly popular and clinicians have been prescribing them for years, therapeutic peptides have only recently entered the mainstream health discussion, leaving many curious strength trainers wondering what options they have and which treatments deserve their consideration